By EPR Editorial Team · Edited on Jun 24, 2026
Inside EPR’s Cannabis Communications coverage · the full Schedule III framework lives in the canonical anchor: Cannabis Communications in the Schedule III Era.
On April 23, 2026, the Department of Justice and DEA moved FDA-approved cannabis products and state-licensed medical cannabis from Schedule I to Schedule III. A broader hearing on recreational cannabis begins June 29, 2026. Brands are reading this as the green light. It isn’t. It’s a half-step. And the marketing implications are very specific — and very actionable.
Here’s what every CMO in cannabis needs to do this quarter.
What Changed for Cannabis Marketing Playbooks
Section 280E of the Internal Revenue Code disappears for state-licensed medical operators. That’s the headline for marketers. Until April 22, cannabis companies couldn’t deduct ordinary business expenses — including marketing, branding, agency fees, paid media, influencer spend. Their effective federal tax rate ran 70 to 80 percent per Cannabis Regulators Association data. Marketing budgets were paid in post-tax dollars at confiscatory rates.
That math just inverted for medical operators. Every dollar of marketing spend now performs roughly 3-4x harder against the bottom line. Translation: your 2026 marketing budget should be bigger — meaningfully bigger — and your CFO should sign off without resistance.
What Didn’t Change
Recreational cannabis remains Schedule I until the June 29 hearing produces a final rule, and that final rule is months away at minimum. Adult-use operators get nothing from this order. Their 280E burden is intact.
More importantly for marketers: the rescheduling does not unlock paid advertising on Google, Meta, or TikTok. Those policies are platform-level decisions, not federal-law decisions. Google, Meta, and TikTok all continue to prohibit cannabis ads regardless of federal classification. Anyone telling you to "spin up Meta campaigns now that cannabis is Schedule III" is either uninformed or selling you something.
The walls didn’t come down. Just the tax wall, and only for medical.
Where Cannabis Marketing Playbooks Should Focus Next
1. Generative Engine Optimization (GEO)
Cannabis consumers researching "best dispensary near me," "highest THC vape 2026," or "where to buy edibles in [city]" now get answers from ChatGPT, Perplexity, Google AI Overviews, and Gemini before they ever click a result. AI Overviews appear in 25.11% of Google searches, up from 13.14% a year prior. Roughly 93% of AI search sessions end without a website click. If your brand isn’t cited inside the AI answer, you don’t exist. The full GEO framework lives at Generative Engine Optimization.
2. Earned Media and Authority Press
Answer engines pull from authoritative, indexed publishers. A brand mention in a high-DA outlet feeds three layers at once: traditional SEO, Google AI Overview citations, and ChatGPT/Perplexity training. PR is no longer a "nice to have" awareness play — it is the pipeline that makes you visible inside AI answers. A single trade-press feature can outperform six months of disallowed paid social.
3. Owned Channels — Email and SMS
No platform risk. No ad bans. Direct line to opted-in customers. Best-in-class cannabis CRM operators pull average order values up 20-40% through lifecycle segmentation, lapsed-customer winback, and AOV-focused offers. The full email playbook lives at Email Marketing in Cannabis — The 2026 Playbook.
4. Influencer Marketing — Done Compliantly
The FTC has escalated enforcement on undisclosed cannabis endorsements. Brands and creators both face liability. Compliant influencer programs need explicit #sponsored disclosures, age-gated audiences, no health claims, and Certificate of Analysis (COA) substantiation for any product reference. The full compliance-first framework lives at Cannabis Influencer Marketing: 2026 Compliance-First Playbook.
5. CTV, DOOH, and X (Twitter)
Connected TV inventory is opening for cannabis with proper geofencing and 21+ targeting. Digital out-of-home billboards remain effective. X allows licensed cannabis advertisers in legal states with verification — the only major social platform that does.
Tactical Execution
File for DEA registration before the June 22, 2026 deadline if you’re a state-licensed medical operator. Without it, your protected operating status during federal review is at risk — and so is the marketing certainty that lets you spend.
Audit your owned channels now. Email list health, SMS opt-in compliance, customer data infrastructure. Most cannabis brands are sitting on first-party data they’ve never properly mined.
Get on the AI citation map. Run prompts against ChatGPT, Perplexity, Gemini, and Google AI Mode for your category. If competitors are getting cited and you aren’t, that gap is now your biggest revenue threat — bigger than any state-license issue. The citation share benchmark for the category lives at AI Refuses 28% of Cannabis Questions.
Stop waiting for federal legalization to fix your marketing problem. The brands that win the next 18 months are building distribution muscle that doesn’t depend on Meta or Google ever turning cannabis ads on.
Schedule III didn’t open the floodgates. It opened a tax window. Brands that move budget into AI visibility, earned media, owned channels, and compliant influencer right now will pull ahead of brands waiting for clarity that isn’t coming this year.
Why Cannabis Brands Are Structurally Ahead in the AI Era
Every cannabis brand operating today learned a hard lesson their counterparts in beverage, beauty, and CPG never had to learn: you cannot buy your way to the customer. Meta, Google, and TikTok have prohibited cannabis ads for years. That forced cannabis marketers to become better at earned media, SEO, owned channels, and content than almost any other consumer category in America.
That muscle just became the most valuable marketing capability in the country — because the rest of the world is now playing the same game.
The Shift Nobody Priced In
ChatGPT now serves roughly 800 million weekly active users and processes billions of prompts. Google AI Overviews reach 1.5 billion monthly users. McKinsey’s October 2025 consumer research found roughly half of all consumers across every demographic — including boomers — intentionally use AI search for purchase decisions. For B2B buyers, the figure has hit 73%.
AI search converts at 14.2% versus 2.8% for Google organic — a 5x advantage. Yet only 22% of marketers track AI visibility. The gap between buyer behavior and marketer response is the single biggest revenue opportunity in marketing right now.
For most categories, this is a transition. For cannabis, it’s a homecoming.
Why Cannabis Brands Are Structurally Ahead
Cannabis brands have been forced to win without paid social since the day they opened. That meant earned media as the primary acquisition engine, SEO at a level CPG brands rarely match, owned channels operating at retail-grade, and influencer programs that survive platform purges. The result: when answer engines started citing brands in answers, cannabis brands were already structured the way LLMs reward — authority press, structured content, third-party validation, owned audiences.
The Citation Graph Advantage
Different answer engines pull from dramatically different sources. Citation volumes for the same brand differ by 615x between platforms. Only 11% of domains are cited by both ChatGPT and Perplexity. ChatGPT shows 6.5% URL overlap with Google’s top 10 results. Two out of three AI citations come from pages users would never see on Google’s first page.
Translation: Google rankings do not equal AI visibility. Optimizing only for traditional SEO is a 2022 strategy.
The sources that move the needle: Wikipedia and Reddit rank in the top citations for ChatGPT and Google AI Mode. High-authority trade and lifestyle publications. Listicles and comparison content account for 21.9% of citations across AI Mode, ChatGPT, and Perplexity, with listicles capturing 40.86% of commercial-intent queries. YouTube and structured FAQ content. YouTube and Reddit combined account for 78.2% of AI social media citations.
Final Takeaway
The brands building AI-visibility infrastructure now will compound their advantage. The brands waiting to see how it shakes out will spend the next two years buying their way back into relevance, in a category where they cannot buy their way anywhere.
Cannabis brands didn’t choose this fight. They were thrown into it. That’s exactly why they are about to win it.
Related Schedule III Coverage
